These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15059965)

  • 1. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury.
    Wright GL; Hanlon P; Amin K; Steenbergen C; Murphy E; Arcasoy MO
    FASEB J; 2004 Jun; 18(9):1031-3. PubMed ID: 15059965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts.
    Yaguchi Y; Satoh H; Wakahara N; Katoh H; Uehara A; Terada H; Fujise Y; Hayashi H
    Circ J; 2003 Mar; 67(3):253-8. PubMed ID: 12604877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart.
    Docherty JC; Kuzio B; Silvester JA; Bowes J; Thiemermann C
    Br J Pharmacol; 1999 Jul; 127(6):1518-24. PubMed ID: 10455304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.
    Chan CY; Chen YS; Lee HH; Huang HS; Lai YL; Chen CF; Ma MC
    Life Sci; 2007 Aug; 81(9):717-23. PubMed ID: 17707437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.
    Cai Z; Manalo DJ; Wei G; Rodriguez ER; Fox-Talbot K; Lu H; Zweier JL; Semenza GL
    Circulation; 2003 Jul; 108(1):79-85. PubMed ID: 12796124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
    Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization.
    Lin JS; Chen YS; Chiang HS; Ma MC
    J Physiol; 2008 Dec; 586(23):5757-69. PubMed ID: 18845609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury.
    Pan H; Li D; Fang F; Chen D; Qi L; Zhang R; Xu T; Sun H
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):535-42. PubMed ID: 21795988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
    Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
    FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
    Headrick JP
    J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.
    Lipsic E; van der Meer P; Henning RH; Suurmeijer AJ; Boddeus KM; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Cardiovasc Pharmacol; 2004 Oct; 44(4):473-9. PubMed ID: 15454856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
    Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
    J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term inhibition of the Na-H exchanger limits acidosis and reduces ischemic injury in the rat heart.
    Schaefer S; Ramasamy R
    Cardiovasc Res; 1997 May; 34(2):329-36. PubMed ID: 9205547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NO in ischemia/reperfusion injury in isolated rat heart.
    Andelová E; Barteková M; Pancza D; Styk J; Ravingerová T
    Gen Physiol Biophys; 2005 Dec; 24(4):411-26. PubMed ID: 16474186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-ischemic contractile dysfunction does not correlate with an elevated intracellular free [Mg2+]: a 31P-NMR study on isolated rat and rabbit hearts.
    Schreur JH; de Beer R; Van Echteld CJ; Ruigrok TJ
    J Mol Cell Cardiol; 1993 Sep; 25(9):1015-24. PubMed ID: 8283465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin protects the systolic function of neonatal hearts against ischaemia/reperfusion injury.
    Vilarinho KA; de Oliveira PP; Saad MJ; Eghtesady P; Filho LM; Vieira RW; Petrucci O
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):156-62. PubMed ID: 22564802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart.
    Lee BH; Seo HW; Yi KY; Lee S; Lee S; Yoo SE
    Eur J Pharmacol; 2005 Mar; 511(2-3):175-82. PubMed ID: 15792786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane and halothane increase adenosine triphosphate preservation, but do not provide additive recovery of function after ischemia, in preconditioned rat hearts.
    Boutros A; Wang J; Capuano C
    Anesthesiology; 1997 Jan; 86(1):109-17. PubMed ID: 9009946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.